Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Comin-Colet J"'
Autor:
McDonagh T; King's College Hospital, London, UK., Damy T; Department of Cardiology, AP-HP, DHU A-TVB and GRC ARI, Henri Mondor University-Hospital, Créteil, France., Doehner W; Department of Cardiology (CVK), Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), and Center for Stroke Research Berlin and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin, Berlin, Germany., Lam CSP; National Heart Centre Singapore, Duke-National University of Singapore, Singapore; and Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Sindone A; Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Repatriation General Hospital, Concord, New South Wales, Australia., van der Meer P; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Cohen-Solal A; Department of Cardiology, Paris Diderot University, Sorbonne Paris Centre, UMRS 942, Lariboisière Hospital, Paris, France., Kindermann I; Department of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine), Saarland University Medical Center, Homburg/Saar, Germany., Manito N; Heart Failure and Transplant Unit, Department of Cardiology, Hospital de Bellvitge, Barcelona, Spain., Pfister O; Department of Cardiology, University Hospital Basel, Basel, Switzerland., Pohjantähti-Maaroos H; Heart Centre, Kuopio University Hospital, Kuopio, Finland., Taylor J; Department of Medicine for the Elderly, Glasgow Royal Infirmary, Glasgow, UK., Comin-Colet J; Community Heart Failure Program, Department of Cardiology, University of Barcelona, Bellvitge University Hospital and IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Publikováno v:
European journal of heart failure [Eur J Heart Fail] 2018 Dec; Vol. 20 (12), pp. 1664-1672. Date of Electronic Publication: 2018 Oct 12.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hans-Dirk Düngen, Margaret M. Redfield, Jean L. Rouleau, Brian Claggett, Faiez Zannad, Aldo P. Maggioni, Junbo Ge, Eva Goncalvesova, Marc A. Pfeffer, Béla Merkely, Inder S. Anand, Jianjian Gong, Sergey Boytsov, Felipe Martinez, José Francisco Kerr Saraiva, Victor Shi, Małgorzata Lelonek, Milton Packer, Martin Lefkowitz, Dirk J. van Veldhuisen, Adel R. Rizkala, Scott D. Solomon, Burkert Pieske, John G.F. Cleland, Akshay S. Desai, Michael R. Zile, Michele Senni, Jingmin Zhou, Sanjiv J. Shah, Tzvetana Katova, Pardeep S. Jhund, Carolyn S.P. Lam, Josep Comín-Colet, John J.V. McMurray
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
New England Journal of Medicine, 381(17), 1609-1620. MASSACHUSETTS MEDICAL SOC
Universidad de Barcelona
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
New England Journal of Medicine, 381(17), 1609-1620. MASSACHUSETTS MEDICAL SOC
Background: \ud The angiotensin receptor–neprilysin inhibitor sacubitril–valsartan led to a reduced risk of hospitalization for heart failure or death from cardiovascular causes among patients with heart failure and reduced ejection fraction. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4eefe59348013f3ae5a9a210b4602d9
https://doi.org/10.1056/nejmoa1908655
https://doi.org/10.1056/nejmoa1908655
Autor:
Martina M. McGrath, Brian Claggett, Dirk J. van Veldhuisen, Marc A. Pfeffer, Finnian R. Mc Causland, Josep Comín-Colet, Milton Packer, Martin Lefkowitz, John J.V. McMurray, Faiez Zannad, Pardeep S. Jhund, Scott D. Solomon, Victor Shi, Nagesh S. Anavekar, Mauro Gori, Michele Senni
Publikováno v:
Circulation, 142(13), 1236-1245. LIPPINCOTT WILLIAMS & WILKINS
Background: In patients with heart failure, chronic kidney disease is common and associated with a higher risk of renal events than in patients without chronic kidney disease. We assessed the renal effects of angiotensin/neprilysin inhibition in pati
Autor:
Faiez Zannad, Andreas J. Flammer, Lars Køber, Yoshihiko Saito, Inder S. Anand, Turia Ben-Gal, Adel R. Rizkala, Davor Miličić, Hans Dirk Duengen, Nancy K. Sweitzer, Junbo Ge, Jiří Widimský, Tzvetana Katova, Robert Zweiker, Chen Huan Chen, Sergio V. Perrone, Margaret M. Redfield, Sanjiv J. Shah, Michael R. Zile, Milton Packer, Jean L. Rouleau, Felipe Martinez, Michele Senni, Juan Luis Arango, Gerard Linssen, Eileen O'Meara, Vijay K. Chopra, Aldo P. Maggioni, Josep Comín-Colet, Bojan Vrtovec, Stefan D. Anker, Jyrki Taurio, Armando Godoy, Scott D. Solomon, Jingmin Zhou, David Sim, Małgorzata Lelonek, Dragos Vinereanu, Michel Galinier, John J.V. McMurray, Carolyn S.P. Lam, Naresh Ranjith, Burkert Pieske, Nagesh S. Anavekar, Béla Merkely, Jose L. Arenas, Sergey Boytsov, John G.F. Cleland, José Francisco Kerr Saraiva, Stefan Janssens, Jianjian Gong, Victor Shi, Dirk J. van Veldhuisen, Eva Goncalvesova, Antonio S. Sibulo, Petar M. Seferovic, Martin Lefkowitz, Byung Hee Oh, Mehmet Yilmaz, Luis E. Echeverría Correa, Marc A. Pfeffer, Lars Lund, Dan Atar, Gerasimos Filippatos
Publikováno v:
Circulation-Heart failure, 11(7):004962. LIPPINCOTT WILLIAMS & WILKINS
WOS: 000438926500008
PubMed ID: 29980595
BACKGROUND: To describe the baseline characteristics of patients with heart failure and preserved left ventricular ejection fraction enrolled in the PARAGON-HF trial (Prospective Comparison of Angiot
PubMed ID: 29980595
BACKGROUND: To describe the baseline characteristics of patients with heart failure and preserved left ventricular ejection fraction enrolled in the PARAGON-HF trial (Prospective Comparison of Angiot